{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T12:45:39Z","timestamp":1756385139818},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,6,2]],"date-time":"2016-06-02T00:00:00Z","timestamp":1464825600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Herz"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1007\/s00059-016-4432-6","type":"journal-article","created":{"date-parts":[[2016,6,2]],"date-time":"2016-06-02T03:52:17Z","timestamp":1464839537000},"page":"45-50","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Transcatheter closure of PFO as secondary prevention of cryptogenic stroke"],"prefix":"10.1007","volume":"42","author":[{"given":"R.","family":"De Vecchis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Baldi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Cantatrione","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,6,2]]},"reference":[{"issue":"6","key":"4432_CR1","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/S0002-9343(00)00599-4","volume":"109","author":"JP Kistler","year":"2000","unstructured":"Kistler JP (2000) Furie KL Patent foramen ovale diameter and embolic stroke: a\u00a0part of the puzzle? Am J Med 109(6):506\u2013507","journal-title":"Am J Med"},{"key":"4432_CR2","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.amjmed.2006.03.021","volume":"120","author":"JE Dalen","year":"2007","unstructured":"Dalen JE (2007) Are patients with a patent foramen ovale at increased risk of stroke? A billion dollar question. Am J Med 120:472\u2013474","journal-title":"Am J Med"},{"issue":"10","key":"4432_CR3","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.ejim.2015.09.017","volume":"26","author":"MK Mojadidi","year":"2015","unstructured":"Mojadidi MK, Christia P, Salamon J et al (2015) Patent foramen ovale: Unanswered questions. Eur J Intern Med 26(10):743\u2013751","journal-title":"Eur J Intern Med"},{"key":"4432_CR4","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ijcard.2013.08.058","volume":"169","author":"G Ntaios","year":"2013","unstructured":"Ntaios G, Papavasileiou V, Makaritsis K, Michel P (2013) PFO closure vs. medical therapy in cryptogenic stroke or transient ischemic attack: a systematic review and meta-analysis. Int J Cardiol 169:101\u2013105","journal-title":"Int J Cardiol"},{"key":"4432_CR5","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1002\/ccd.25122","volume":"82","author":"AM Pineda","year":"2013","unstructured":"Pineda AM, Nascimento FO, Yang SC et al (2013) A meta-analysis of transcatheter closure of patent foramen ovale versus medical therapy for prevention of recurrent thromboembolic events in patients with cryptogenic cerebrovascular events. Catheter Cardiovasc Interv 82:968\u2013975","journal-title":"Catheter Cardiovasc Interv"},{"key":"4432_CR6","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1161\/STROKEAHA.113.001773","volume":"44","author":"GD Kitsios","year":"2013","unstructured":"Kitsios GD, Thaler DE, Kent DM (2013) Potentially large yet uncertain benefits:a meta-analysis of patent foramen ovale closure trials. Stroke 44:2640\u20132643","journal-title":"Stroke"},{"key":"4432_CR7","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/1471-2261-13-116","volume":"13","author":"IB Riaz","year":"2013","unstructured":"Riaz IB, Dhoble A, Mizyed A et al (2013) Transcatheter patent foramen ovale closure versus medical therapy for cryptogenic stroke: a meta-analysis of randomized clinical trials. BMC Cardiovasc Disord 13:116","journal-title":"BMC Cardiovasc Disord"},{"key":"4432_CR8","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.carrev.2013.08.010","volume":"14","author":"A Hakeem","year":"2013","unstructured":"Hakeem A, Marmagkiolis K, Hacioglu Y et al (2013) Safety and efficacy of device closure for patent foramen ovale for secondary prevention of neurological events: comprehensive systematic review and meta-analysis of randomized controlled trials. Cardiovasc Revasc Med 14:349\u2013355","journal-title":"Cardiovasc Revasc Med"},{"key":"4432_CR9","doi-asserted-by":"crossref","first-page":"4132","DOI":"10.1016\/j.ijcard.2013.07.077","volume":"168","author":"JS Kwong","year":"2013","unstructured":"Kwong JS, Lam YY, Yu CM (2013) Percutaneous closure of patent foramen ovale for cryptogenic stroke: a meta-analysis of randomized controlled trials. Int J Cardiol 168:4132\u20134138","journal-title":"Int J Cardiol"},{"key":"4432_CR10","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.hlc.2013.07.022","volume":"22","author":"V Nagaraja","year":"2013","unstructured":"Nagaraja V, Raval J, Eslick GD, Burgess D, Denniss AR (2013) Is transcatheter closure better than medical therapy for cryptogenic stroke with patent foramen ovale? A meta-analysis of randomised trials. Heart Lung Circ 22:903\u2013909","journal-title":"Heart Lung Circ"},{"key":"4432_CR11","doi-asserted-by":"crossref","first-page":"3342","DOI":"10.1093\/eurheartj\/eht285","volume":"34","author":"P Rengifo-Moreno","year":"2013","unstructured":"Rengifo-Moreno P, Palacios IF, Junpaparp P et al (2013) Patent foramen ovale transcatheter closure vs. medical therapy on recurrent vascular events: a systematic review and meta-analysis of randomized controlled trials. Eur Heart J 34:3342\u20133352","journal-title":"Eur Heart J"},{"key":"4432_CR12","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1016\/j.jcin.2013.08.001","volume":"6","author":"AR Khan","year":"2013","unstructured":"Khan AR, Bin Abdulhak AA, Sheikh MA et\u00a0al (2013) Device closure of patent foramen ovale versus medical therapy in cryptogenic stroke. JACC Cardiovasc Interv 6:1316\u20131323","journal-title":"JACC Cardiovasc Interv"},{"key":"4432_CR13","doi-asserted-by":"crossref","first-page":"e004282","DOI":"10.1136\/bmjopen-2013-004282","volume":"4","author":"FA Spencer","year":"2014","unstructured":"Spencer FA, Lopes LC, Kennedy SA, Guyatt G (2014) Systematic review of percutaneous closure versus medical therapy in patients with cryptogenic stroke and patent foramen ovale. BMJ Open 4:e004282","journal-title":"BMJ Open"},{"key":"4432_CR14","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1136\/heartjnl-2013-304394","volume":"100","author":"M Wolfrum","year":"2014","unstructured":"Wolfrum M, Froehlich GM, Knapp G et al (2014) Stroke prevention by percutaneous closure of patent foramen ovale: a systematic review and meta-analysis. Heart 100:389\u2013395","journal-title":"Heart"},{"key":"4432_CR15","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.4244\/EIJV9I11A225","volume":"9","author":"D Capodanno","year":"2014","unstructured":"Capodanno D, Milazzo G, Vitale L et al (2014) Updating the evidence on patent foramen ovale closure versus medical therapy in patients with cryptogenic stroke: a systematic review and comprehensive meta-analysis of 2,303 patients from three randomised trials and 2,231 patients from 11 observational studies. EuroIntervention 9:1342\u20131349","journal-title":"EuroIntervention"},{"key":"4432_CR16","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.hlc.2013.12.003","volume":"23","author":"A Pandit","year":"2014","unstructured":"Pandit A, Aryal MR, Pandit AA et al (2014) Amplatzer PFO occluder device may prevent recurrent stroke in patients with patent foramen ovale and cryptogenic stroke: a meta-analysis of randomised trials. Heart Lung Circ 23:303\u2013308","journal-title":"Heart Lung Circ"},{"issue":"10","key":"4432_CR17","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.cjca.2014.05.004","volume":"30","author":"JA Udell","year":"2014","unstructured":"Udell JA, Opotowsky AR, Khairy P et al (2014) Patent foramen ovale closure vs medical therapy for stroke prevention: meta-analysis of randomized trials and review of heterogeneity in meta-analyses. Can J Cardiol 30(10):1216\u20131224","journal-title":"Can J Cardiol"},{"issue":"8","key":"4432_CR18","first-page":"CD009938","volume":"9","author":"J Li","year":"2015","unstructured":"Li J, Liu J, Liu M et al (2015) Closure versus medical therapy for preventing recurrent stroke in patients with patent foramen ovale and a history of cryptogenic stroke or transient ischemic attack. Cochrane Database Syst Rev 9(8):CD009938","journal-title":"Cochrane Database Syst Rev"},{"issue":"11","key":"4432_CR19","first-page":"991","volume":"366","author":"AJ Furlan","year":"2012","unstructured":"Furlan AJ, Reisman M, Massaro J et al (2012) Closure or medical therapy for cryptogenic stroke with patent foramen ovale. N Engl J Med 366(11):991\u2013999","journal-title":"Mar"},{"key":"4432_CR20","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1056\/NEJMoa1211716","volume":"368","author":"B Meier","year":"2013","unstructured":"Meier B, Kalesan B, Mattle HP et\u00a0al (2013) Percutaneous closure of patent foramen ovale in cryptogenic embolism. N Engl J Med 368:1083\u20131091","journal-title":"N Engl J Med"},{"key":"4432_CR21","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1056\/NEJMoa1301440","volume":"368","author":"JD Carroll","year":"2013","unstructured":"Carroll JD, Saver JL, Thaler DE et\u00a0al (2013) Closure of patent foramen ovale versus medical therapy after cryptogenic stroke. N Engl J Med 368:1092\u20131100","journal-title":"N Engl J Med"},{"key":"4432_CR22","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1161\/STR.0000000000000024","volume":"45","author":"KernanWN","year":"2014","unstructured":"KernanWN, Ovbiagele B, Black HR et\u00a0al (2014) Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke 45:2160\u20132236","journal-title":"Stroke"},{"issue":"9","key":"4432_CR23","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1016\/j.jacc.2005.08.038","volume":"46","author":"H Hara","year":"2005","unstructured":"Hara H, Virmani R, Ladich E et al (2005) Patent foramen ovale: current pathology, pathophysiology, and clinical status. J Am Coll Cardiol 46(9):1768\u20131776","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"4432_CR24","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0025-6196(12)60336-X","volume":"59","author":"PT Hagen","year":"1984","unstructured":"Hagen PT, Scholz DG, Edwards WD (1984) Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts. Mayo Clin Proc 59(1):17\u201320","journal-title":"Mayo Clin Proc"},{"issue":"7","key":"4432_CR25","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1161\/CIRCULATIONAHA.104.524371","volume":"112","author":"S Homma","year":"2005","unstructured":"Homma S, Sacco RL (2005) Patent foramen ovale and stroke. Circulation 112(7):1063\u20131072","journal-title":"Circulation"},{"key":"4432_CR26","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/0002-9149(92)90210-P","volume":"70","author":"D Hausmann","year":"1992","unstructured":"Hausmann D, M\u00fcgge A, Becht I, Daniel WG (1992) Diagnosis of patent foramen ovale by transesophageal echocardiography and association with cerebral and peripheral embolic events. Am J Cardiol 70:668\u2013672","journal-title":"Am J Cardiol"},{"key":"4432_CR27","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1001\/jama.294.3.366","volume":"294","author":"WH Maisel","year":"2005","unstructured":"Maisel WH, Laskey WK (2005) Patent foramen ovale closure devices: moving beyond equipoise. JAMA 294:366\u2013369","journal-title":"JAMA"},{"issue":"7","key":"4432_CR28","doi-asserted-by":"crossref","first-page":"425","DOI":"10.3949\/ccjm.81a.14066","volume":"81","author":"J Tobis","year":"2014","unstructured":"Tobis J (2014) Patent foramen ovale and the risk of cryptogenic stroke. Cleve Clin J Med 81(7):425\u2013426","journal-title":"Cleve Clin J Med"},{"issue":"456","key":"4432_CR29","first-page":"462","volume":"109","author":"HW Schuchlenz","year":"2000","unstructured":"Schuchlenz HW, Weihs W, Horner S, Quehenberger F (2000) The association between the diameter of a patent foramen ovale and the risk of embolic cerebrovascular events. Am J Med 109(456):462","journal-title":"Am J Med"},{"key":"4432_CR30","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/j.amjcard.2007.12.040","volume":"101","author":"M Taaffe","year":"2008","unstructured":"Taaffe M, Fischer E, Baranowski A et\u00a0al (2008) Comparison of three patent foramen ovale closure devices in a randomized trial (Amplatzer versus CardioSEAL\u2013STARflex versus Helex occluder). Am J Cardiol 101:1353\u20131358","journal-title":"Am J Cardiol"},{"key":"4432_CR31","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1136\/hrt.2002.003111","volume":"90","author":"M Schwerzmann","year":"2004","unstructured":"Schwerzmann M, Windecker S, Wahl A et al (2004) Per-cutaneous closure of patent foramen ovale: impact of device design on safety and efficacy. Heart 90:186\u2013190","journal-title":"Heart"}],"container-title":["Herz"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00059-016-4432-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00059-016-4432-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00059-016-4432-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00059-016-4432-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T11:33:23Z","timestamp":1498304003000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00059-016-4432-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,2]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["4432"],"URL":"https:\/\/doi.org\/10.1007\/s00059-016-4432-6","relation":{},"ISSN":["0340-9937","1615-6692"],"issn-type":[{"value":"0340-9937","type":"print"},{"value":"1615-6692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,2]]}}}